Check our media releases of the recent months. To view all media releases, go to the archive. To be put on our distribution list for media releases click here.

August 20, 2010
	Difficult start to first half-year of 2010 for the Bachem Group
June 17, 2010
	Bachem sells stake in Polyphor to Ingro Finanz AG
June 2, 2010
	Bachem to supply ISA Pharmaceuticals with finished dosage forms immunotherapeutic HPV-SLP for phase III clinical trials
March 19, 2010
	Bachem confirms high profitability also in the business year 2009
September 24, 2009
	mondoBIOTECH and Bachem agree long-term cooperation on the development of peptides to fight rare diseases
August 14, 2009
	Bachem Group Half-Year Results 2009
May 26, 2009
	Stephan Schindler to become new CFO of Bachem Group
April 23, 2009
	Annual General Meeting elects new member of the Board of Directors
March 31, 2009
	Bachem and Debiopharm sign follow-up contract for long-term supply of Triptorelin Pamoate
March 13, 2009
	Bachem announces financial results for the business year 2008
January 28, 2009
	Bionor Immuno and Bachem sign agreement on supply of active ingredients and finished dosage forms for Bionor Immuno's vaccine development projects
September 17, 2008
	Bachem enlarges Corporate Executive Committee
August 15, 2008
	Bachem Group Half-Year Result 2008
April 10, 2008
	Action Pharma and Bachem cooperate on AP214 - now ready to enter Phase 2 clinical trials
March 14, 2008
	Record year for Bachem at all levels in 2007
February 4, 2008
	Bachem production facilities licensed for the manufacture of APIs for the Japanese market
August 17, 2007
	New record results for Bachem in the first half of 2007
August 9, 2007
	Bachem Joint Venture Pevion Biotech Secures CHF 35 Million in Series A Financing Round
June 20, 2007
	Bachem renews supply agreement with AstraZeneca
June 18, 2007
	Bachem acquires Clinalfa from Merck Biosciences
May 30, 2007
	Bachem and Intercell agree long-term supply contract for peptide component of vaccine adjuvant IC31
May 9, 2007
	Neuren and Bachem continue close collaboration on Glypromate
March 16, 2007
	Bachem reports record results on 2006 sales and profit
January 11, 2007
	Bachem and Ardana sign long-term Supply Agreement for Aviptadil
August 18, 2006
	Bachem posts sharp rise in profits in the first half of 2006
July 27, 2006
	Bachem Completes Expansion of Peptide Manufacturing Capacities in the US
April 7, 2006
	Bachem reports record year: highest turnover in the company's history and marked net income growth
March 29, 2006
	Bachem Group with new production unit for cytotoxic substances
March 21, 2006
	mondoBIOTECH and Bachem sign collaboration agreement for the development of new projects deriving from the Bachem Peptide Library
March 16, 2006
	Bachem and Debio conclude long-term supply agreement for triptorelin pamoate
March 9, 2006
	Swedish Orphan International and Bachem conclude long-term supply agreement for nitisinone
January 27, 2006
	Bachem 2005 - Strong second half drives record sales
August 16, 2005
	Bachem announces half-year results and confirms positive perspective for the second half of 2005
June 29, 2005
	Bachem continues its commitment to peptide chemistry at the University of Basel
April 28, 2005
	mondoBIOTECH and Bachem sign a collaboration agreement for the development and production of Thymopentin
April 26, 2005
	Michael Hüsler designated successor to Reto Conrad as Bachem CFO
April 8, 2005
	Bachem 2004 results with positive outlook for 2005
January 21, 2005
	Bachem 2004 - Active pharmaceutical ingredients drive growth
August 17, 2004
	Bachem half-year sales 2004 exceed CHF 75 million
July 28, 2004
	mondoBIOTECH and Bachem sign a collaborative development and manufacturing agreement for Aviptadil production
June 18, 2004
	Pevion Biotech announces positive results in clinical phase I trial for its malaria vaccine
April 20, 2004
	Bachem increases net income by 11.4% in 2003
March 18, 2004
	Jerini and Bachem announce collaboration for Icatibant production
January 23, 2004
	Full Year Sales 2003: Bachem reports continued sales growth for its active pharmaceutical ingredients business
August 22, 2003
	Bachem Group increases half-year net income with stable sales in local markets
April 24, 2003
	Bachem maintains above-average profitability despite difficult economic conditions
January 23, 2003
	Bachem grows sales by 9.7% in local currencies
January 22, 2003
	Bachem and AstraZeneca extend supply agreement
January 20, 2003
	Bachem Professorship for Peptide Chemistry Extended to 2005

archive